Pharmacokinetic Studies on 1-(2-Chloroethyl)-3-Isobutyl-3-(.Beta.-Maltosyl)-1-Nitrosourea (TA-077). III. Pharmacokinetics of a New Nitrosourea Antitumor Agent TA-077 in Humans (A Phase I Study).

Journal of Pharmacobio-Dynamics
doi 10.1248/bpb1978.10.523

Related search